(Q34532620)

2 August 2017

1 reference

title

Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? (English)

1 reference

2 August 2017

0 references

Grüber C

1

1 reference

PubMed ID

11846867

2 August 2017

Nilsson L

series ordinal

2

1 reference

PubMed ID

11846867

2 August 2017

Björkstén B

series ordinal

3

1 reference

2 August 2017

1 December 2001

1 reference

Pediatric Allergy & Immunology

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

6

1 reference

2 August 2017

296-311

1 reference

The environmental influence on childhood asthma

2 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Family size, childhood infections and atopic diseases. The Aberdeen WHEASE Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Early childhood infection and atopic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Family size, infections, and asthma prevalence in New Zealand children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Role of microbial burden in aetiology of allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Atopy in children of families with an anthroposophic lifestyle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Immunoglobulin E and G antibodies two years after a booster dose of an aluminium-adsorbed or a fluid DT vaccine in relation to atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

IgE synthesis in man *1II. Comparison of tetanus and diphtheria IgE antibody in allergic and nonallergic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Early BCG vaccination and development of atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guérin-vaccinated and nonvaccinated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Early BCG vaccination and reduction in atopy in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

T Lymphocyte Numbers and Function in Human IgE-Mediated Allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Differential CD4 T cell activation in measles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Changes in plasma IgE levels during complicated and uncomplicated measles virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Mechanism of suppression of cell-mediated immunity by measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Cell mediated immunity after measles in Guinea-Bissau: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Measles and atopy in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Childhood exposure to infection and risk of adult onset wheeze and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Measles history and atopic diseases: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Common allergens in avian meats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Clinical and immunological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Safe administration of the measles vaccine to children allergic to eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Measles immunisation in children with allergy to egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Safe administration of influenza vaccine to patients with egg allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

The relevance of TH1 and TH2 cells in immediate and nonimmediate reactions to gelatin-containing vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Anaphylaxis after hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Thiomersal allergy and vaccination reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Merthiolate hypersensitivity and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Allergen avoidance in the treatment of asthma and atopic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

CpG DNA and LPS induce distinct patterns of activation in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

The third function of the thymus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

T regulatory cells 1 inhibit a Th2-specific response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Effect of adjuvant therapy on development of diabetes in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Is Infant Immunization a Risk Factor for Childhood Asthma or Allergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Thimerosal in Vaccines—An Interim Report to Clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

Increased risk of allergy in children due to formaldehyde exposure in homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

A low pregnancy body mass index is a risk factor for an offspring with gastroschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Adjuvant effect of pertussis toxin on the production of anti-ovalbumin IgE in mice and lack of direct correlation between PCA and ELISA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

The non-specific enhancement of allergy. I. In vivo effects of Bordetella pertussis vaccine on IgE synthesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

1 reference

7 January 2021

Biological activities of crystalline pertussigen from Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Specific IgE-antibodies to Bordetella pertussis antigens during whooping cough

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Does pertussis infection induce manifestation of allergy?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Respiratory sequelae of whooping cough. Swansea Research Unit of the Royal College of General Practitioners

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Specific IgE antibodies to Bordetella pertussis after immunisation in infancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Pertussis in infancy does not increase the risk of asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Specific IgE antibodies to Bordetella pertussis after immunisation in infancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Pertussis IgE and atopic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

A randomized controlled trial of the effect of pertussis vaccines on atopic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Adverse reactions to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Immediate local reaction to tetanus toxoid booster

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

IgE antibodies to tetanus toxoid in relation to atopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Immunoglobulin E-suppressing and immunoglobulin G-enhancing tetanus toxoid prepared by conjugation with pullulan

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Evaluation of tuberculin reactivity in BCG-immunized siblings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Development of tuberculin reactivity and sensitization to M. scrofulaceum and M. fortuitum in children BCG-vaccinated at birth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccines.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Long term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Reactions to thimerosal in hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Allergic mechanisms and urticaria/angioedema after hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Mechanisms of adjuvancy: I--Metal oxides as adjuvants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Occupational asthma caused by aluminum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Injection-site granuloma due to aluminum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Vaccination granulomas and aluminium allergy: course and prognostic factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

The safety of egg-containing vaccines for egg-allergic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Measles immunization in children with a history of egg allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Safety of Influenza Vaccination in Allergic Children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Development of IgE antibody to gelatin in children with systemic immediate-type reactions to vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Sensitization to thimerosal in atopic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Exposure to formaldehyde and phenol during an anatomy dissecting course: sensitizing potency of formaldehyde in medical students

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Safe MMR vaccination despite neomycin allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

DNA from Mycobacterium bovis bacillus Calmette-Guérin (MY-1) inhibits immunoglobulin E production by human lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

Microbe exposure, innate immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.1R046.X

7 January 2021

10.1034/J.1399-3038.2001.1R046.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11846867